ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
84 hedge funds and large institutions have $173M invested in ChemoCentryx, Inc. in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 11 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $173M → $173M (-$179K)
6% less funds holding
Funds holding: 89 → 84 (-5)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $89K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.4M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.9M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$1.38M |
| 4 |
Renaissance Technologies
New York
|
+$1.05M |
| 5 |
SIM
Spark Investment Management
New York
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.75M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.65M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.48M |
| 4 |
D.E. Shaw & Co
New York
|
-$573K |
| 5 |
CFIC
City Financial Investment Company
London,
United Kingdom
|
-$497K |
CCXI Hedge Fund Activity: Q1 2017 in Review
84 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2017, worth a combined $173M — down 0.1% from $173M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CCXI positions and 11 closed out — a net gain of 1 holder — while 30 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock, adding an estimated $15.4M. The largest seller was Wasatch Advisors, cutting an estimated $2.75M.
- 84 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2017, down from 89 in Q4 2016.
- Funds reported $173M of ChemoCentryx, Inc. stock for Q1 2017, down 0.1% quarter-over-quarter.
- 12 funds opened new ChemoCentryx, Inc. positions in Q1 2017 and 11 closed out, a net change of +1 holder.
- The largest ChemoCentryx, Inc. buyer in Q1 2017 was BlackRock, an estimated $15.4M added.
- The largest ChemoCentryx, Inc. seller in Q1 2017 was Wasatch Advisors, an estimated $2.75M sold.
Based on aggregated 13F filings for Q1 2017.